Matachana And Device Technologies Bring Together Decades Of Sterilisation Expertise For Australian And New Zealand Healthcare
Sydney, Australia — The Matachana Device Technologies partnership will combine decades of sterilisation and infection prevention expertise. The agreement covers Australia and New Zealand.
Matachana will appoint Device Technologies as its exclusive distributor in both markets. The appointment takes effect on 1 January 2027.
Both organisations have extensive experience in sterilisation and infection prevention. Matachana has developed sterilisation and reprocessing solutions for more than 60 years.
Device Technologies entered the sterilisation category in 1993. Since then, it has worked with leading global manufacturers. The company has introduced and supported sterilisation technologies across Australian and New Zealand healthcare environments.
Matachana Device Technologies Partnership Builds On Decades Of Experience
Device Technologies has spent more than three decades building relationships across the healthcare sector. These include hospitals, healthcare professionals and Central Sterile Services Departments.
The company supports surgical sterilisation and medical device reprocessing across Australia and New Zealand.
Heath Priestly, CEO of Device Technologies, said the appointment builds on an important part of the company’s history and capability.
“Sterilisation has been part of Device Technologies’ business since 1993. Over more than three decades, we have developed a deep understanding of the technologies, operating environments and support required by sterilisation and medical device reprocessing departments across Australia and New Zealand.
“Matachana is an established global specialist with a strong commitment to quality, innovation and technical expertise. There is a close alignment between our organisations, and we look forward to working together to support the continued development of the portfolio across the region.”
Matachana Brings More Than 60 Years Of Sterilisation Expertise
Matachana was founded in 1962. The company develops and manufactures equipment and integrated solutions for sterilisation, washing, disinfection and infection prevention.
Matachana serves the Healthcare, Life Science and Pharma sectors. Its technologies support hospitals, laboratories and pharmaceutical environments around the world.
Under the Matachana Device Technologies partnership, Device Technologies will become Matachana’s exclusive distributor in Australia and New Zealand. The agreement covers Matachana sterilisation solutions and starts on 1 January 2027.
Matachana Device Technologies Partnership To Support Regional Growth
Device Technologies and Matachana will work together ahead of the January 2027 appointment. Their goal is to ensure a smooth transition.
The companies will also support the continued growth of Matachana’s sterilisation portfolio across Australia and New Zealand.
About Device Technologies
Device Technologies is a renowned medical technology company. It provides healthcare solutions, medical equipment and technology from leading brands across Australia, New Zealand and Asia.
The company works with more than 200 trusted brands and has 1000 highly skilled staff. Device Technologies aims to enable superior health outcomes by providing medical devices and hospital supplies.
About Matachana
Founded in 1962, Matachana is a family-owned company. It specialises in sterilisation, washing, disinfection and infection prevention solutions.
The company serves the Healthcare, Life Science and Pharma sectors.
Today, Matachana has a presence in 139 countries. It designs, manufactures and supports integrated solutions for hospitals, laboratories and pharmaceutical environments.
These solutions aim to improve safety, efficiency and quality in daily operations. Matachana combines more than 60 years of technical expertise with continuous innovation and strong service support.
Cybersecurity And Healthcare Technology
As hospitals connect more clinical and operational equipment to digital systems, cybersecurity has become part of broader healthcare resilience. Sterilisation and medical device reprocessing environments are particularly important because disruption can affect the availability of equipment required for clinical care.
The Matachana and Device Technologies announcement does not outline specific cybersecurity measures associated with the partnership. However, security, system availability and operational resilience remain important considerations when healthcare organisations deploy and support connected technology.